Updates are available Correction dated 2022-12-02
Click to view Correction: https://doi.org/10.1186/s41232-022-00246-2
-
Authors
Yamagata, Kaoru
Nakayamada, Shingo
Zhang, Tong
Nguyen, Anh Phuong
Ohkubo, Naoaki
Iwata, Shigeru
Kato, Shigeaki
Tanaka, Yoshiya https://orcid.org/0000-0002-0807-7139
-
Funding
Funding for this research was provided by:
Grants-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan
Grants-In-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI #19K08925)
grant-in-aid from the University of Occupational and Environmental Health, Japan for Advanced Research
- License Information
-
More Information
Article History
Received: 24 June 2022
Accepted: 16 October 2022
First Online: 3 November 2022
Change Date: 2 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s41232-022-00246-2
Declarations
:
: This study was approved by the Ethics Review Committee for Medical Research of the University of Occupational and Environmental Health, Japan (approval #H28-067). Each study participant provided a signed informed consent before study participation. The study was conducted in accordance with the Declaration of Helsinki and its subsequent modifications.
: Not applicable.
: Y. Tanaka has received consulting fees, speaking fees, and/or honoraria from Daiichi-Sankyo, Astellas, Pfizer, Mitsubishi-Tanabe, Bristol-Myers, Chugai, YL Biologics, Eli Lilly, Sanofi, Janssen, UCB, and has received research grants from Mitsubishi-Tanabe, Takeda, Bristol-Myers, Chugai, Astellas, Abbvie, MSD, Daiichi-Sankyo, Pfizer, Kyowa-Kirin, Eisai, and Ono. S. Nakayamada has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers, Pfizer, GlaxoSmithKline, Sanofi, Astellas, Asahi-kasei, Boehringer Ingelheim and has received research grants from Mitsubishi-Tanabe, Novartis and Novartis. The other authors declare that they have no competing interests.
